Stamakort
Khavinson natural peptide complex derived from stomach tissue — studied for gastric mucosal regeneration, acid secretion normalization, and chronic gastritis support.
🔬 Mechanism of Action
Stamakort is a Khavinson Cytomax derived from gastric mucosal tissue, containing stomach-specific peptides that regulate gene expression in parietal cells, chief cells, and mucin-producing foveolar cells.
Stamakort modulates: (1) H+/K+ ATPase (proton pump) expression in parietal cells for normalized acid secretion, (2) pepsinogen production by chief cells for protein digestion, (3) MUC5AC and MUC6 mucin expression for mucosal barrier integrity, and (4) trefoil factor (TFF1, TFF2) production — key repair peptides for gastric epithelial wound healing.
In Khavinson GI protocols, Stamakort is used for chronic atrophic gastritis, age-related digestive decline, and mucosal barrier restoration after H. pylori eradication therapy.
Source: PMID: 15677927
📜Background & History
Stamakort is the stomach Cytomax extract, supporting gastric mucosal health.
🎯 Research Use Cases
- ✓Gastric health
- ✓Chronic gastritis support
- ✓Mucosal repair
💉 Dosing Protocol
| Typical Dose | 1-2 capsules/day |
| Frequency | 1-2× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
⚠️Safety & Considerations
Standard oral Cytomax capsule protocol. May complement BPC-157 in GI protocols.
⚡Interactions & Contraindications
Standard Cytomax capsule protocol.
🔗Synergies & Common Stacks
Stamakort (gastric gene regulation) + BPC-157 (growth factor-mediated GI repair) = complementary GI healing approaches.